ROHAN PALEKAR - 05 Jun 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role: Chief Executive Officer, Director
Signature: /s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Issuer symbol: ETNB
Transactions as of: 05 Jun 2023
Net transactions value: -$271,050
Form type: 4
Filing time: 07 Jun 2023, 17:04:21 UTC
Previous filing: 04 Apr 2023
Next filing: 09 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ETNB	Common Stock	Options Exercise	$28,950	+15,000	+5.2%	$1.93^*	301,978	05 Jun 2023	Direct	F1
transaction	ETNB	Common Stock	Sale	$300,000	-15,000	-5%	$20.00	286,978	05 Jun 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ETNB	Stock Option (Right to Buy)	Options Exercise	$0	-15,000	-7.1%	$0.000000	195,231	05 Jun 2023	Common Stock	15,000	$1.93	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes an aggregate of 8 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on December 30, 2022.
F2	This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2022.
F3	This option is vested in full.
F4	Due to an administrative error, the exercise of an aggregate of 15,000 options was erroneously omitted from the Form 4 filed by the Reporting Person on March 27, 2023. This form reflects the correct amount of stock options owned by the Reporting Person.